Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy (Q34636539)

3 August 2017

Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy (English)

1 reference

3 August 2017

Clostridium difficile

0 references

author name string

Mark A Miller

1

1 reference

3 August 2017

Thomas Louie

2

1 reference

3 August 2017

Kathleen Mullane

3

1 reference

3 August 2017

Karl Weiss

4

1 reference

3 August 2017

Arnold Lentnek

5

1 reference

3 August 2017

Yoav Golan

6

1 reference

3 August 2017

Yin Kean

7

1 reference

3 August 2017

Pam Sears

8

1 reference

3 August 2017

language of work or name

1 reference

25 March 2013

1 reference

3 August 2017

BMC Infectious Diseases

1 reference

3 August 2017

13

1 reference

3 August 2017

148

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

start time

25 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-13-148

0 references

cites work

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Inventory of Cancer Guidelines: a tool to advance the guideline enterprise and improve the uptake of evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Comparison of clinical severity score indices for Clostridium difficile infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Fidaxomicin versus vancomycin for Clostridium difficile infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Treatment with monoclonal antibodies against Clostridium difficile toxins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Clinical risk factors for severe Clostridium difficile-associated disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618004

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

Severe Clostridium difficile colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

Predictors of serious complications due to Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

Explaining basic categories: Feature predictability and information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-148

21 January 2018

Identifiers

DOI

10.1186/1471-2334-13-148

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference